CRENEUROS
LIVE

Serial Number

98741847

Owner

Fidelity BioPharma Co.

Attorney

John Alumit

First Use Date

Nov 20, 2024

Filing Date

Sep 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CRENEUROS Trademark

Serial Number: 98741847 • Registration: 8147098

CRENEUROS is a trademark filed by Fidelity BioPharma Co. on September 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Fidelity BioPharma Co. (22 trademarks)

157 CHURCH STREET, SUITE 1915
NEW HAVEN, CT 06510

Entity Type: 03

Trademark Details

Filing Date

September 9, 2024

Registration Date

February 17, 2026

First Use Anywhere

November 20, 2024

First Use in Commerce

November 20, 2024

Published for Opposition

April 8, 2025

Goods & Services

Dietary supplements; Dietary supplements also containing coenzyme q10; Dietary and nutritional supplements; Dietary and nutritional supplements containing fish oil; Herbal supplements; Mineral dietary supplements; Nutritional supplements; Probiotic supplements; Vitamin supplements; Vitamin and mineral supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 17, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 17, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 26, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 26, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 21, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 21, 2026 AITU
USE AMENDMENT FILED
Jul 16, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 16, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 3, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 15, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 14, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWOS
NEW APPLICATION ENTERED
Sep 10, 2024 NWAP